The Norwegian Inflammation Network (NORIN) is holding a seminar on Wednesday, 29 October entitled Sufficient options to treat inflammation? Looking at the pipeline of the pharmaceutical industry.
Register by October 24th.
Norwegian Inflammation Network
Wednesday 29 October 2014 at 15:00, Domus Medica, "Rotunde," Runde auditorium (GA21 R-105), Sognvannsveien 9, University of Oslo
"Sufficient options to treat inflammation? Looking at the pipeline of the pharmaceutical industry"
|Tore Kvien, University of Oslo/Diakonhjemmet Hospital|
"What has been achieved with new drugs and treatment strategies and which gaps need to be addressed in the future management of inflammatory rheumatic diseases?"
|Jon Florholmen, University Hospital of North Norway |
"Challenges in biological treatment of inflammatory bowel disease"
|Alexandre Corthay, University of Oslo/Oslo University Hospital|
"Introduction to pipeline targets"
Loredana Regep, Medical Director, Roche
Erik Hjelvin, Medical Director, Pfizer
Steinar Thoresen, Medical Director, Abbvie
|NETWORKING WITH TAPAS AND WINE|
Register by 24 October: https://nettskjema.uio.no/answer/61387.html